Chugai Pharmaceutical Co Ltd
TSE:4519
Chugai Pharmaceutical Co Ltd
TSE:4519
Price:
7 130
JPY
0.01%
Market Closed
Market Cap:
11.7T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Chugai Pharmaceutical Co Ltd
7130
+1 (+0.01%)
| 52 Week Range |
4 684
7 855
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Chugai Pharmaceutical Co Ltd
Income Statement
Earnings Waterfall
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
|
Revenue
|
1.1T
JPY
|
|
Cost of Revenue
|
-337.2B
JPY
|
|
Gross Profit
|
805.2B
JPY
|
|
Operating Expenses
|
-265B
JPY
|
|
Operating Income
|
540.2B
JPY
|
|
Other Expenses
|
-153.2B
JPY
|
|
Net Income
|
387B
JPY
|
Income Statement
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
Currency: JPY
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
450 546
N/A
|
461 109
+2%
|
454 147
-2%
|
479 265
+6%
|
495 454
+3%
|
498 840
+1%
|
501 650
+1%
|
506 193
+1%
|
492 585
-3%
|
491 781
0%
|
497 355
+1%
|
497 024
0%
|
517 909
+4%
|
534 199
+3%
|
556 158
+4%
|
566 547
+2%
|
572 994
+1%
|
579 787
+1%
|
586 649
+1%
|
614 950
+5%
|
662 198
+8%
|
686 184
+4%
|
711 320
+4%
|
734 019
+3%
|
753 853
+3%
|
786 946
+4%
|
776 339
-1%
|
809 054
+4%
|
887 918
+10%
|
999 759
+13%
|
1 191 495
+19%
|
1 205 696
+1%
|
1 143 716
-5%
|
1 259 726
+10%
|
1 211 632
-4%
|
1 243 437
+3%
|
1 276 050
+3%
|
1 111 367
-13%
|
1 036 075
-7%
|
1 084 569
+5%
|
1 142 350
+5%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(211 115)
|
(218 076)
|
(220 314)
|
(232 689)
|
(239 469)
|
(240 238)
|
(243 680)
|
(248 031)
|
(245 378)
|
(247 944)
|
(247 929)
|
(244 359)
|
(250 590)
|
(254 171)
|
(256 834)
|
(261 796)
|
(262 676)
|
(262 847)
|
(262 925)
|
(261 758)
|
(269 834)
|
(264 732)
|
(263 434)
|
(269 931)
|
(265 269)
|
(273 465)
|
(267 530)
|
(265 020)
|
(299 856)
|
(337 680)
|
(397 233)
|
(408 997)
|
(373 899)
|
(476 251)
|
(513 156)
|
(524 995)
|
(534 155)
|
(412 650)
|
(334 928)
|
(331 206)
|
(337 168)
|
|
| Gross Profit |
239 431
N/A
|
243 033
+2%
|
233 833
-4%
|
246 576
+5%
|
255 985
+4%
|
258 602
+1%
|
257 970
0%
|
258 162
+0%
|
247 207
-4%
|
243 837
-1%
|
249 426
+2%
|
252 665
+1%
|
267 319
+6%
|
280 028
+5%
|
299 324
+7%
|
304 751
+2%
|
310 318
+2%
|
316 940
+2%
|
323 724
+2%
|
353 192
+9%
|
392 364
+11%
|
421 452
+7%
|
447 886
+6%
|
464 088
+4%
|
488 584
+5%
|
513 481
+5%
|
508 809
-1%
|
544 034
+7%
|
588 062
+8%
|
662 079
+13%
|
794 262
+20%
|
796 699
+0%
|
769 817
-3%
|
783 475
+2%
|
698 476
-11%
|
718 442
+3%
|
741 895
+3%
|
698 717
-6%
|
701 147
+0%
|
753 363
+7%
|
805 182
+7%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(159 718)
|
(167 174)
|
(168 313)
|
(170 624)
|
(172 202)
|
(171 818)
|
(171 883)
|
(171 075)
|
(168 847)
|
(166 953)
|
(166 250)
|
(172 193)
|
(172 837)
|
(181 094)
|
(188 373)
|
(186 349)
|
(189 705)
|
(192 617)
|
(191 669)
|
(200 386)
|
(205 075)
|
(206 939)
|
(210 972)
|
(207 914)
|
(211 546)
|
(211 298)
|
(216 022)
|
(222 754)
|
(231 315)
|
(233 840)
|
(249 325)
|
(248 533)
|
(246 921)
|
(249 525)
|
(249 228)
|
(256 279)
|
(269 771)
|
(253 785)
|
(259 906)
|
(266 656)
|
(265 004)
|
|
| Selling, General & Administrative |
(84 305)
|
(86 374)
|
(86 853)
|
(87 367)
|
(86 211)
|
(88 018)
|
(87 772)
|
(86 313)
|
(85 480)
|
(81 941)
|
(81 247)
|
(82 463)
|
(82 410)
|
(88 147)
|
(89 630)
|
(89 710)
|
(91 553)
|
(93 416)
|
(92 379)
|
(97 894)
|
(99 844)
|
(100 676)
|
(102 068)
|
(96 920)
|
(95 498)
|
(92 992)
|
(94 547)
|
(96 491)
|
(98 993)
|
(100 754)
|
(107 888)
|
(106 840)
|
(104 721)
|
(99 583)
|
(96 520)
|
(107 753)
|
(112 702)
|
(111 916)
|
(114 150)
|
(108 201)
|
(108 439)
|
|
| Research & Development |
(75 413)
|
(80 800)
|
(81 459)
|
(83 257)
|
(85 990)
|
(83 799)
|
(84 111)
|
(84 761)
|
(83 366)
|
(85 011)
|
(85 000)
|
(89 728)
|
(90 426)
|
(92 947)
|
(98 743)
|
(96 638)
|
(98 150)
|
(99 202)
|
(99 289)
|
(102 491)
|
(105 231)
|
(104 733)
|
(108 903)
|
(110 995)
|
(116 049)
|
(116 601)
|
0
|
(96 538)
|
(102 597)
|
(131 276)
|
(141 438)
|
(141 694)
|
(142 201)
|
(148 059)
|
(153 976)
|
(164 487)
|
(173 192)
|
(169 061)
|
(172 867)
|
(171 475)
|
(170 981)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 530)
|
0
|
0
|
0
|
(1 705)
|
0
|
0
|
0
|
(1 810)
|
0
|
0
|
0
|
(1 820)
|
0
|
0
|
0
|
(1 369)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
(1)
|
0
|
0
|
(1)
|
(2)
|
1
|
0
|
(2)
|
(1)
|
0
|
0
|
1
|
0
|
0
|
(121 475)
|
(29 725)
|
(29 725)
|
0
|
0
|
1
|
0
|
(63)
|
1 268
|
15 961
|
16 123
|
28 561
|
27 111
|
13 020
|
14 416
|
|
| Operating Income |
79 713
N/A
|
75 859
-5%
|
65 520
-14%
|
75 952
+16%
|
83 783
+10%
|
86 784
+4%
|
86 087
-1%
|
87 087
+1%
|
78 360
-10%
|
76 884
-2%
|
83 176
+8%
|
80 472
-3%
|
94 482
+17%
|
98 934
+5%
|
110 951
+12%
|
118 402
+7%
|
120 613
+2%
|
124 323
+3%
|
132 055
+6%
|
152 806
+16%
|
187 289
+23%
|
214 513
+15%
|
236 914
+10%
|
256 174
+8%
|
277 038
+8%
|
302 183
+9%
|
292 787
-3%
|
321 280
+10%
|
356 747
+11%
|
428 239
+20%
|
544 937
+27%
|
548 166
+1%
|
522 896
-5%
|
533 950
+2%
|
449 248
-16%
|
462 163
+3%
|
472 124
+2%
|
444 932
-6%
|
441 241
-1%
|
486 707
+10%
|
540 178
+11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(72)
|
304
|
554
|
628
|
350
|
555
|
149
|
135
|
584
|
1 262
|
632
|
468
|
318
|
4
|
8
|
35
|
(74)
|
444
|
609
|
614
|
406
|
519
|
(407)
|
1
|
(523)
|
(1 575)
|
(606)
|
(777)
|
403
|
56
|
1 355
|
1 819
|
(363)
|
769
|
(242)
|
365
|
3 008
|
4 240
|
3 297
|
2 397
|
39
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(64)
|
0
|
0
|
0
|
(160)
|
0
|
0
|
0
|
(97)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3 916)
|
0
|
0
|
0
|
(953)
|
0
|
0
|
0
|
(6 342)
|
0
|
0
|
0
|
(641)
|
(4 651)
|
(4 892)
|
(5 052)
|
(5 758)
|
(489)
|
(248)
|
0
|
|
| Total Other Income |
1
|
1
|
0
|
1
|
2
|
1
|
(1)
|
1
|
0
|
(3 538)
|
(4 539)
|
(3 884)
|
(4 558)
|
(1 810)
|
(1 230)
|
(2 817)
|
(2 729)
|
(3 318)
|
(3 447)
|
(3 186)
|
(3 300)
|
(3 223)
|
(2 820)
|
(2 498)
|
(2 062)
|
(1 467)
|
(968)
|
(625)
|
(3 155)
|
(2 568)
|
(4 941)
|
(4 936)
|
(2 142)
|
(2 912)
|
268
|
268
|
267
|
407
|
0
|
0
|
0
|
|
| Pre-Tax Income |
79 642
N/A
|
76 164
-4%
|
66 075
-13%
|
76 581
+16%
|
84 134
+10%
|
87 276
+4%
|
86 236
-1%
|
87 223
+1%
|
78 945
-9%
|
74 448
-6%
|
79 269
+6%
|
77 056
-3%
|
90 242
+17%
|
97 031
+8%
|
109 729
+13%
|
115 620
+5%
|
117 810
+2%
|
121 449
+3%
|
129 217
+6%
|
150 234
+16%
|
184 395
+23%
|
207 893
+13%
|
233 687
+12%
|
253 677
+9%
|
274 453
+8%
|
298 188
+9%
|
291 213
-2%
|
319 878
+10%
|
353 995
+11%
|
419 385
+18%
|
541 351
+29%
|
545 049
+1%
|
520 391
-5%
|
531 166
+2%
|
444 623
-16%
|
457 904
+3%
|
470 347
+3%
|
443 821
-6%
|
444 048
+0%
|
488 855
+10%
|
540 217
+11%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(26 165)
|
(24 087)
|
(18 258)
|
(23 133)
|
(24 048)
|
(24 923)
|
(24 009)
|
(23 645)
|
(21 472)
|
(20 076)
|
(20 864)
|
(18 169)
|
(21 721)
|
(23 490)
|
(26 760)
|
(29 566)
|
(31 248)
|
(28 370)
|
(29 260)
|
(36 947)
|
(44 792)
|
(50 333)
|
(59 625)
|
(63 080)
|
(71 864)
|
(83 455)
|
(80 603)
|
(89 301)
|
(97 533)
|
(116 390)
|
(153 991)
|
(156 037)
|
(149 600)
|
(156 737)
|
(128 468)
|
(130 934)
|
(133 602)
|
(118 349)
|
(117 676)
|
(133 816)
|
(153 254)
|
|
| Income from Continuing Operations |
53 477
|
52 077
|
47 817
|
53 448
|
60 086
|
62 353
|
62 227
|
63 578
|
57 473
|
54 372
|
58 405
|
58 887
|
68 521
|
73 541
|
82 969
|
86 054
|
86 562
|
93 079
|
99 957
|
113 287
|
139 603
|
157 560
|
174 062
|
190 597
|
202 589
|
214 733
|
210 610
|
230 577
|
256 462
|
302 995
|
387 360
|
389 012
|
370 791
|
374 429
|
316 155
|
326 970
|
336 745
|
325 472
|
326 372
|
355 039
|
386 963
|
|
| Income to Minority Interest |
(1 016)
|
(1 097)
|
(1 030)
|
(1 227)
|
(1 189)
|
(1 228)
|
(1 184)
|
(1 040)
|
(908)
|
(780)
|
(811)
|
(744)
|
(817)
|
(827)
|
(868)
|
(767)
|
(704)
|
(591)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
52 461
N/A
|
50 980
-3%
|
46 786
-8%
|
52 220
+12%
|
58 897
+13%
|
61 125
+4%
|
61 043
0%
|
62 537
+2%
|
56 562
-10%
|
53 592
-5%
|
57 592
+7%
|
58 142
+1%
|
67 704
+16%
|
72 713
+7%
|
82 101
+13%
|
85 287
+4%
|
85 858
+1%
|
92 488
+8%
|
99 632
+8%
|
113 071
+13%
|
139 544
+23%
|
157 560
+13%
|
174 063
+10%
|
190 598
+9%
|
202 590
+6%
|
214 733
+6%
|
210 611
-2%
|
230 578
+9%
|
256 463
+11%
|
302 995
+18%
|
387 360
+28%
|
389 012
+0%
|
370 791
-5%
|
374 429
+1%
|
316 154
-16%
|
326 969
+3%
|
336 745
+3%
|
325 472
-3%
|
326 373
+0%
|
355 040
+9%
|
386 963
+9%
|
|
| EPS (Diluted) |
96.08
N/A
|
93.38
-3%
|
85.53
-8%
|
95.46
+12%
|
107.67
+13%
|
37.26
-65%
|
111.61
+200%
|
114.33
+2%
|
103.41
-10%
|
32.66
-68%
|
105.28
+222%
|
106.29
+1%
|
123.77
+16%
|
44.28
-64%
|
149.81
+238%
|
155.63
+4%
|
156.67
+1%
|
56.27
-64%
|
60.59
+8%
|
68.76
+13%
|
84.84
+23%
|
95.81
+13%
|
105.83
+10%
|
115.87
+9%
|
123.15
+6%
|
130.53
+6%
|
128.02
-2%
|
140.15
+9%
|
155.88
+11%
|
184.17
+18%
|
235.44
+28%
|
236.5
+0%
|
225.39
-5%
|
227.57
+1%
|
192.14
-16%
|
198.71
+3%
|
204.63
+3%
|
197.8
-3%
|
198.34
+0%
|
215.75
+9%
|
235.11
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
